Role of TP53 Mutations and EGFR Amplification in Risk Stratification of Early‐Stage EGFR‐Mutated Non‐Small Cell Lung Cancer With Immunohistochemistry as a Surrogate Marker

Role of TP53 Mutations and EGFR Amplification in Risk Stratification of Early‐Stage EGFR‐Mutated Non‐Small Cell Lung Cancer With Immunohistochemistry as a Surrogate Marker

ABSTRACT Background Non‐small cell lung carcinoma (NSCLC) is a leading cause of cancer‐related mortality, with recurrence risks posing significant challenges in early‐stage disease management. While epidermal growth factor receptor (EGFR) mutations are common, the role of concurrent genetic alterati...

Full description

Saved in:
Bibliographic Details
Main Authors: Meejeong Kim, Gyeong Sin Park, Kyo Young Lee, Seok Whan Moon, Yeoun Eun Sung
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:Thoracic Cancer
Subjects:
early‐stage lung cancer
EGFR amplification
EGFR mutation
non‐small cell lung cancer (NSCLC)
TP53 mutation
Online Access:https://doi.org/10.1111/1759-7714.70058
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1111/1759-7714.70058

Similar Items